Condition
Treatment Outcome
ClinicalTrials.gov condition label
Clinical trials
10 shownFlumazenil for Benzodiazepine Reversal in Electroconvulsive TherapyNCT07619092 · 2026-01-15
RECRUITINGA Real World Study of Sacituzumab GovitecanNCT06966141 · 2024-08-12
RECRUITINGThe STEREO-DBS Study: 7-Tesla MRI Brain Network Analysis for Deep Brain StimulationNCT05843084 · 2022-04-11
RECRUITINGPrecision Medicine in the Depression TreatmentNCT05616559 · 2021-06-15
RECRUITINGThe Effect of Psychosocial Skills Focused Group Psychoeducation in Schizophrenia PatientsNCT06872424 · 2025-04-15
NOT_YET_RECRUITINGEffect of Latanoprost on Optic Nerve PerfusionNCT06629129 · 2024-06-24
COMPLETEDBleeding Intracerebral Hemorrhage With Early Invasive Intracranial Pressure Monitoring TrialNCT05593380 · 2022-11-15
COMPLETEDPattern Scanning Laser Pan-retinal Photocoagulation in Proliferative Diabetic RetinopathyNCT02816073 · 2012-12-01
COMPLETEDVortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual DysfunctionNCT01364649 · 2011-06-01
COMPLETEDProspective Outcomes After Reconstruction and Radiotherapy for Breast CancerNCT00845078 · 2008-12-01
WITHDRAWNCommon interventions
7T MRI network analysis for deep brain stimulation in Parkinson's diseasePROCEDURE1Electroconvulsive therapy (ECT)PROCEDURE1EscitalopramDRUG1FlumazenilDRUG1Latanoprost (0.005%)DRUG1Pan-retinal photocoagulation using pattern scanning laserDEVICE1Parenchymal Intracranial pressure monitorDEVICE1PlaceboDRUG1psychosocial skills-oriented group psychoeducationBEHAVIORAL1Treatment based on clinical and imaging observationsOTHER1Treatment Package for First-Episode DepressionCOMBINATION_PRODUCT1VortioxetineDRUG1
Leading sponsors
Trial status mix
COMPLETED4
RECRUITING4
NOT_YET_RECRUITING1
WITHDRAWN1
Phase mix
NA4
PHASE11
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.